Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing the hit-to-lead process using SPR analysis.

Stefan Löfås1

  • 1Biacore International AB, Uppsala, Sweden. stefan.lofas@biacore.com

Assay and Drug Development Technologies
|September 11, 2004
PubMed
Summary

Surface plasmon resonance (SPR) streamlines drug discovery bottlenecks by providing kinetic data on compound-target interactions. This label-free technology enhances lead optimization and candidate selection for preclinical development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Label-free kinetic binding data as a decisive element in drug discovery.

Expert opinion on drug discovery·2013
Same author

Biacore systems: leading the revolution in label-free interaction analysis.

Biointerphases·2010
Same author

Comparison of methods for generating planar DNA-modified surfaces for hybridization studies.

ACS applied materials & interfaces·2010
Same author

Surface plasmon optical studies of carboxymethyl dextran brushes versus networks.

Langmuir : the ACS journal of surfaces and colloids·2006
Same author

Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level.

Analytical chemistry·2004
Same author

Attomolar sensitivity in bioassays based on surface plasmon fluorescence spectroscopy.

Journal of the American Chemical Society·2004

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Drug discovery involves secondary screening and lead optimization, which are critical bottlenecks.
  • Traditional end-point assays provide limited information for molecule selection.
  • Label-free technologies offer potential solutions for streamlining these processes.

Purpose of the Study:

  • To highlight the role of Surface Plasmon Resonance (SPR) biosensors in overcoming drug discovery bottlenecks.
  • To demonstrate how SPR can provide kinetic data for enhanced lead optimization.
  • To showcase the advantages of SPR over traditional assays in candidate molecule selection.

Main Methods:

  • Utilizing Surface Plasmon Resonance (SPR) biosensors for label-free analysis of biomolecular interactions.
  • Generating kinetic data on binding characteristics, including affinity, specificity, and kinetics (association/dissociation rates).
  • Integrating SPR into the hit-to-lead process for comprehensive data acquisition.

Main Results:

  • SPR biosensors provide quantitative kinetic data on lead compound-target interactions.
  • Advanced SPR systems offer deeper insights than traditional end-point assays.
  • SPR facilitates informed decision-making in selecting drug candidates for preclinical development.

Conclusions:

  • SPR is a powerful tool for streamlining secondary screening and lead optimization in drug discovery.
  • SPR biosensors enable more informed selection of drug candidates by providing detailed kinetic and binding information.
  • The application of SPR extends to quantitative structure-activity relationship analysis and predictive ADMET evaluations.

Related Experiment Videos